Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)

Last updated: April 11, 2023
Sponsor: Rennes University Hospital
Overall Status: Completed

Phase

N/A

Condition

Circulation Disorders

Lung Injury

Heart Attack (Myocardial Infarction)

Treatment

N/A

Clinical Study ID

NCT03262155
35RC16_3037_IMPECstudy
  • Ages > 18
  • All Genders

Study Summary

Study of immunosuppression biomarkers in patients with ARDS or cardiogenic shock with ECMO / ECLS, compared to patients with ARDS or cardiogenic shock without ECMO / ECLS

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient older than 18 years old
  • Patient hospitalized in an intensive care unit
  • Patient whose initial ARDS or Cardiogenic shock began less than 5 days beforeadmission
  • Patients hospitalized for ARDS or Cardiogenic shock with ECMO / ECLS or - Patientshospitalized for ARDS or Cardiogenic shock without ECMO / ECLS

Exclusion

Exclusion Criteria:

  • Opposition of patient, relative or legal representative for participation in the study
  • Pregnant woman
  • Pre-immunodepression
  • Implementation of immunosuppressive therapy such as chemotherapy, cyclophosphamide,high-dose corticosteroids (> 0.5mg / kg / day).

Study Design

Total Participants: 18
Study Start date:
January 01, 2017
Estimated Completion Date:
January 31, 2019

Connect with a study center

  • CHU de Rennes

    Rennes, 35033
    France

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.